Quick Answer
Twist Bioscience Corp reported Diluted EPS of $1.30 per share (loss) for fiscal year 2025.
Twist Bioscience Corp Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$1.30 | +63.9% |
| 2024 | -$3.60 | +0.0% |
| 2023 | -$3.60 | +10.9% |
| 2022 | -$4.04 | -28.3% |
| 2021 | -$3.15 | +11.8% |
| 2020 | -$3.57 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | -$0.50 | +5.7% | -251.5% |
| June 30, 2025 | $0.33 | +122.4% | +150.0% |
| March 31, 2025 | -$0.66 | +16.5% | -24.5% |
| December 31, 2024 | -$0.53 | +29.3% | +63.9% |
| June 30, 2024 | -$1.47 | -45.5% | -86.1% |
| March 31, 2024 | -$0.79 | +24.0% | -5.3% |
| December 31, 2023 | -$0.75 | -1.4% | +25.7% |
| June 30, 2023 | -$1.01 | +6.5% | +2.9% |
- Twist Bioscience Corp showed an increase of +63.9% in Diluted EPS compared to the prior fiscal year.
- Over the 2020–2025 period, Twist Bioscience Corp’s diluted eps has grown by 63.6% (from $3.57 per share (loss) to $1.30 per share (loss)).
- The most recent figure is from Twist Bioscience Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on November 17, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: